Journal of Applied Physiology, Vol 79, Issue 2 589-593, Copyright © 1995 by American Physiological Society

ARTICLES

L-arginine-related responses to pressure and vasoactive agents in monocrotaline-treated rat pulmonary arteries

J. A. Madden, P. A. Keller, J. S. Choy, T. A. Alvarez and A. D. Hacker
Research Service, Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin, USA.

To determine whether altered NO production contributes to attenuated distensibility (alpha), vasoreactivity, and acetylcholine (ACh) dilation in pulmonary arteries from monocrotaline (MCT)-treated rats (J.A. Madden, P.A. Keller, R. M. Effrosa, C. Sequitte, J.S. Choy, and A.D. Hacker. J. Appl. Physiol. 76: 1589-1593, 1994), intralobar and sidebranch arteries from rats 21 days after MCT treatment were cannulated and pressurized and their diameter changes in response to KCl, norepinephrine, angiotensin II, and pressure were measured in the presence of N omega-nitro-L-arginine (NLA) and L-arginine. NLA treatment decreased MCT artery diameters more than normal arteries (P < 0.05) and abolished ACh dilation in both. Agonist responses were greater in normal but not MCT arteries. The alpha increased in NLA-treated normal (P < 0.05) but not MCT arteries. After L-arginine, normal and MCT arteries returned to control diameters and dilated to ACh. Agonist responses returned to control in normal but not MCT arteries. Normal but not MCT arteries dilated in calcium-free solution (P < 0.05). These results suggest that pulmonary arteries from rats with MCT-induced pulmonary hypertension produce more NO than do pulmonary arteries; inhibiting NO does not increase contractility; and decreased vasoreactivity and alpha values are not due to smooth muscle cell tone but may be due to abnormal vascular remodeling.

This article has been cited by other articles:

				R. M. F. Berger, A. H. Cromme-Dijkhuis, W. C. J. Hop, M. N. Kruit, and J. Hess Pulmonary Arterial Wall Distensibility Assessed by Intravascular Ultrasound in Children With Congenital Heart Disease* : An Indicator for Pulmonary Vascular Disease? Chest, August 1, 2002; 122(2): 549 - 557. [Abstract] [Full Text] [PDF]

				R. C. Tyler, M. Muramatsu, S. H. Abman, T. J. Stelzner, D. M. Rodman, K. D. Bloch, and I. F. McMurtry Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, February 1, 1999; 276(2): L297 - L303. [Abstract] [Full Text] [PDF]

				H. F. Frasch, C. Marshall, and B. E. Marshall Endothelin-1 is elevated in monocrotaline pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, February 1, 1999; 276(2): L304 - L310. [Abstract] [Full Text] [PDF]

				S. Prie, D. J. Stewart, and J. Dupuis EndothelinA Receptor Blockade Improves Nitric Oxide–Mediated Vasodilation in Monocrotaline-Induced Pulmonary Hypertension Circulation, June 2, 1998; 97(21): 2169 - 2174. [Abstract] [Full Text] [PDF]

				J. C. Parker, E. C. Breen, and J. B. West High vascular and airway pressures increase interstitial protein mRNA expression in isolated rat lungs J Appl Physiol, November 1, 1997; 83(5): 1697 - 1705. [Abstract] [Full Text] [PDF]